Skip to content

Collaborative Approach to Examining Adversity and Building Resilience Study

Collaborative Approach to Examining Adversity and Building Resilience Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05259436
Acronym
CARE
Enrollment
300
Registered
2022-02-28
Start date
2022-04-11
Completion date
2025-06-30
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Stress, Early Life Adversity

Brief summary

To examine the behavioral, psychosocial, and biologic impact of resilience-promoting interventions associated with primary care.

Detailed description

Early-life trauma and related adversities are prevalent and associated with negative health and achievement outcomes. These adverse childhood experiences (ACEs) are especially common in economically disadvantaged and communities of color. While there has been tremendous growth in knowledge about ACEs and their impact on health across the life course, critical gaps persist: 1) Which biologic pathways are most affected by ACEs during early childhood and may help identify those children at greatest risk for future poor health? And, 2) How may child and family resilience be bolstered across the care continuum to mitigate the negative health effects of ACEs? These critical gaps severely limit our ability to effectively identify children at high-risk and to intervene to promote resilience before poor health occurs. Three previously piloted resilience-promoting, caregiver-child interventions will be examined: primary care-based, group-delivered Resilience Clinic (RC); home-based, dyadic Attachment and Biobehavioral Catch-up (ABC); and primary care-based, dyadic Resiliency Family Program (RFP). Using a randomized wait- list controlled trial design,12 families will be assigned to intervention or enhanced primary care (n=50/arm in each intervention, total n=300). Pre-post intervention health (behavioral, caregiver stress) and biology will be compared between intervention and controls, as well as modifying factors such as setting and delivery method.

Interventions

BEHAVIORALCaregiver-child Intervention

Intervention Groups: 1. Resilience Clinic (Benioff Oakland): 6 weekly interactive group-based visits in primary care that draws from the evidence-based Circle of Security Parenting along with the principles of mindfulness; 2. ABC Intervention (Lifelong): 10 weekly home visiting sessions. ABC is an empirically supported parenting program that focuses on improving maternal sensitivity; and, 3. Resiliency Family Program (Santa Barbara Neighborhood Clinic): 4 primary-care-based visits, every 2-3 weeks, that include psycho-education materials drawing from the culturally-responsive, evidence-based program, Madres a Madres.

Enhanced Primary Care (control group): This includes care coordination services for community resources in addition to usual care. Participants will be asked about any unmet social needs, e.g. food insecurity, financial strain, safe places to play. Those who endorse need will be offered navigational services to link to community resources.

Sponsors

Lifelong Medical Care
CollaboratorUNKNOWN
UCSF Benioff Children's Hospital Oakland
CollaboratorOTHER
Santa Barbara Neighborhood Clinics
CollaboratorUNKNOWN
University of California, Santa Barbara
CollaboratorOTHER
Futures Without Violence
CollaboratorUNKNOWN
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Participants will be randomly assigned to the caregiver-child intervention using a block allocation scheme. Given the nature of the intervention the participants and their healthcare providers will be unblinded to their assignment.

Intervention model description

Wait-list randomized controlled trial.

Eligibility

Sex/Gender
ALL
Age
2 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Regular access to web-based computer, smart phone, or tablet if necessary to delivery via telehealth due to the COVID19 Pandemic (relative

Exclusion criteria

- have budgeted to provide tablets and mobile wifi hot spots for up to 10% of participants) 2. Attachment and Biobehavioral Catch-up (ABC) Program * Caregiver: 18 years old and older, primary caregiver, English or Spanish speaking * Child: 2 to 4 years, PEARLS score \> 1 3. Resilience Clinic * Caregiver: 18 years old and older, primary caregiver, English or Spanish speaking * Child: 2 to 5 years, PEARLS score \> 1 or verbal disclosure of PEARLS adversity to primary care clinician/staff 4. HEROES Family Program * Caregiver: 18 years old and older, primary caregiver, ACE score \> 2 if child PEARLS score = 0, English or Spanish speaking * Child: 2 to 5 years, PEARLS score \> 1

Design outcomes

Primary

MeasureTime frameDescription
Change in Parenting Stress Index (PSI) scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsCaregiver reported survey validated measure of parenting stress. The Parenting Stress Index - Short Form (PSI) is a 36-item self-report measure completed by parents to measure stress level within the context of parenting. Participants respond to items on a 5-point Likert scale. Responses to each item in a sub-category are totaled to calculate three subcategory scores, which are summed to represent a total parenting stress score. Higher scores indicate higher levels of parenting stress.
Change in Child Behavior Checklist (CBCL) total problems scale scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsCaregiver reported survey validated measure of child behavioral and emotional challenges on the Child Behavior Checklist (CBCL) Preschool form from The Achenbach System of Empirically Based Assessment (ASEBA). The CBCL is standardized for children ages 1.5 to 5 years. Respondents are asked to rate 99 problem items as 0 for not true of the child, 1 for somewhat or sometimes true of the child, and 2 for very true or often true of the child based on the past two months. The range of possible values is 0-100.

Secondary

MeasureTime frameDescription
Change in caregiver anxiety (GAD) total scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsCaregiver reported survey validated measure of self-report symptoms of general anxiety on the General Anxiety Disorder (GAD) questionnaire. Respondents are asked 7 questions to rate from 0 for not at all to 3 for nearly every day based on the past two weeks. The range of possible values is from 0-21. Higher score indicates higher self-report general anxiety symptoms.
Change in family cohesion total scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsThe Family Adaptability and Cohesion Evaluation Scales II (FACES II) family cohesion scale evaluates eight concepts (2 items each): emotional bonding, family boundaries, coalitions, time, space, friends, decision-making, and interest and recreation. Respondents rate from 1 for almost never or never to 5 for almost always or always. A higher score indicates high family cohesion.
Change in adult reported social and emotional support (ARSES) total scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsAdult-reported social and emotional support is assessed using a standardized single item, How often do you get the social and emotional support you need? Response choices were always, usually, sometimes, rarely, or never.
Change in atopy (ISSAC screen)baseline/enrollment and 2 week and 3-month follow-up after intervention endsISAAC was an epidemiological study following a survey of 2 million children worldwide to evaluate the prevalence of atopic disease in various ethnic backgrounds. The questionnaire is self-reported by parents and children to evaluate asthma, allergic rhinitis and eczema in childhood. 21 items, core questionnaires to assess the prevalence and severity of asthma, rhinitis and eczema in defined populations.
Change in general stress (Perceived Stress Scale) total scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsThe Perceived Stress Scale measures the extent to which an individual perceives situations in his or her life as stressful. It is a measure of global perceived stress and asks about feelings and thoughts during the last month. Respondents are asked 10 questions to rate from 0 for never to 4 for very often based on the past month. The range of possible values is from 0-40. Higher score indicates higher perceived stress.
Change in health-related social needs (Accountable Health Communities total score)baseline/enrollment and 2 week and 3-month follow-up after intervention endsQuestionnaire assessing impacts of current unmet health-related social needs (6 items; housing instability and problems, food insecurity, transportation needs, problems paying for utilities/bills) and number of current social needs. Questionnaire assessing impacts of current unmet health-related social needs (6 items; housing instability and problems, food insecurity, transportation needs, problems paying for utilities/bills) and number of current social needs. Questionnaire assessing impacts of current unmet health-related social needs (6 items; housing instability and problems, food insecurity, transportation needs, problems paying for utilities/bills) and number of current social needs.
Telomere lengthbaseline/enrollment and 3-month follow-up after intervention endsTelomeres are nucleoproteins that protect the ends of chromosomes. Telomere length is a biomarker of cellular aging. Chronic stress has been associated with shorter telomere length.
Leptinbaseline/enrollment and 3-month follow-up after intervention endsLeptin is a hormone primarily secreted by fat cells to reduce hunger.
Change in global health (PROMIS global health)baseline/enrollment and 2 week and 3-month follow-up after intervention endsPROMIS® (Patient-Reported Outcomes Measurement Information System®) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. This study uses the first question on the global scale, with minimum value of 1 and maximum of 5. Higher scores mean better general health.
IGFBP1baseline/enrollment and 3-month follow-up after intervention endsInsulin-like growth factor binding protein 1 is mainly expressed in the liver and circulates in plasma where it interacts with IGF-1 and 2. IGFBP-1 plays an important role in metabolism and low levels of this protein has associated with impaired glucose tolerance and hypertension
HA1Cbaseline/enrollment and 3-month follow-up after intervention endsThe hemoglobin A1c (glycated hemoglobin, glycosylated hemoglobin, HbA1c, or A1c) test is used to evaluate a person's level of glucose control. The test shows an average of the blood sugar level over the past 90 days and represents a percentage.
blood pressurebaseline/enrollment and 3-month follow-up after intervention endsSystolic and diastolic blood pressure, averaged across 3 readings.
resting heart ratebaseline/enrollment and 3-month follow-up after intervention endsNumber of beats per minutes.
waist circumferencebaseline/enrollment and 3-month follow-up after intervention endsMeasuring waist circumference in cm. Waist and hip measurements will be combined to report waist-hip ratio (WHR) as a dimensionless ratio of the circumference of the waist to that of the hips.
hip circumferencebaseline/enrollment and 3-month follow-up after intervention endsMeasuring hip circumference in cm. Waist and hip measurements will be combined to report waist-hip ratio (WHR) as a dimensionless ratio of the circumference of the waist to that of the hips.
weightbaseline/enrollment and 3-month follow-up after intervention endsWeight will be measured in kg. Weight and height will be combined to report BMI in kg/m\^2
heightbaseline/enrollment and 3-month follow-up after intervention endsHeight will be measured in cm. Weight and height will be combined to report BMI in kg/m\^2
CRPbaseline/enrollment and 3-month follow-up after intervention endsC-reactive protein is produced by the liver in response to inflammation. Higher level of CRP in the blood is an indicator of inflammation.
Change in caregiver depression (PHQ) total scorebaseline/enrollment and 2 week and 3-month follow-up after intervention endsCaregiver reported survey validated measure of self-report depressive symptoms on the Patient Health Questionnaire (PHQ). Respondents are asked 8 questions to rate from 0 for not at all to 3 for nearly every day based on the past two weeks. The range of possible values is from 0-27. Higher scores indicate higher self-report depressive symptoms.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026